Vir Biotechnology Enters Exclusive Worldwide License Agreement With Sanofi For Three Clinical-Stage Masked T-Cell Engagers And Use Of Protease-Cleavable Masking Platform For Oncology And Infectious Diseases
Author: Benzinga Newsdesk | August 01, 2024 04:07pm